In China, Dr. Reddy’s laboratories Ltd. operates through its joint venture with Rotam Group of Canada. The joint venture is widely known as Kunshan Rotam Reddy Pharmaceutical Co., Ltd. (KRRP).
KRRP was established in Year 2000 complying with China laws, situated in Kunshan Economic & Technological Development Zone (KETD), which is a state-level investor-friendly development zone with abundant infrastructure facilities and scientific talents.
All our Active Pharmaceutical Ingredient (API) products and Finished Dosage (FD) plants (tablet, capsule, cream, and imported repacking tablet) have gained GMP certificates from SFDA. KRRP is equipped with an in-house research institute specializing in new product development and a team of highly-qualified personnel is actively developing new products in the focus therapeutic areas of Central Nervous System (CNS), Gastroenterology, Cardiology, Endocrinology, Dermatology, Rheumatology, and so on. We have robust product pipeline and a host of products are at different stages of registration. We have been seeking best from better, continuously advancing technology level, and enhancing efficiency of operations as well as improving quality standards.
KRRP has been able to establish a strong presence in CNS, Dermatology, Gastroenterology and Endocrinology segments with its brands. Across China market, KRRP is ranked No. 1 in promotion of Anti gout product and No. 3 in promotion of one of the CNS product. KRRP has a well-established distribution network covering almost all Of China and products of KRRP are available in several hospitals and pharmacies all over China.